Previous Close | 0.7728 |
Open | 0.7202 |
Bid | 0.7501 x 1200 |
Ask | 0.8569 x 900 |
Day's Range | 0.7202 - 0.8278 |
52 Week Range | 0.7200 - 2.1000 |
Volume | |
Avg. Volume | 69,245 |
Market Cap | 42.259M |
Beta (5Y Monthly) | 0.41 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.7700 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for MOVE
Movano Health (Nasdaq: MOVE) announced today that the Evie Ring, the smart ring designed specifically for women's health, has received a 2024 CES Innovation Honoree Award in the wearables category.
Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announces the successful ecommerce launch of the Evie Ring, the innovative smart ring designed for women, which has exceeded the Company's commercial sales goals driving over $1 million in orders through the Thanksgiving Holiday.
Movano Health (Nasdaq: MOVE) begins taking orders for the Evie Ring, the smart ring designed specifically for women, today at 12 pm EST. An innovative and comfortable form factor, a focus on helping women track and analyze their health and fitness, and an emphasis on big-picture data interpretation rather than individual activity scores set Evie apart from other wearables, providing a valuable new tool for women seeking to take control of their health.